Delivery Order SPE2DE24D0013-SPE2D625F5X6L
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $2,040 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, under contract XPRS4PLEX-10. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, represents a continuation of Cepheid's ongoing provision of diagnostic solutions to federal healthcare systems. The contract carries no set-aside designation,...
- The U.S. Defense Department's Medical Supply Chain awarded a $27,235.80 firm fixed-price delivery order to Cepheid Inc. on June 6, 2025, with an ultimate completion date of June 13, 2025. This delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions, specializing in advanced GeneXpert diagnostic systems and...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,093.57 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on June 3, 2025, with an ultimate completion date of June 10, 2025. The contract, designated XPRSTREPA-10, carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. Cepheid specializes in...
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The U.S. Defense Department's Medical Supply Chain division awarded a $29,520 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, with an ultimate completion date of September 5, 2025. The contract, which carries no set-aside designation, is for molecular diagnostic solutions to be performed at Cepheid's facility in Sunnyvale, California. Cepheid, a for-profit manufacturer of advanced diagnostic systems and test kits, specializes in detecting infectious diseases and clinical...
- The U.S. Defense Department's Medical Supply Chain division awarded a $95,200 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, with final completion scheduled for September 5, 2025. This delivery order, designated XPRS4PLEX-10, carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in GeneXpert diagnostic systems and associated...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $2,097.20 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on May 2, 2025, with an ultimate completion date of May 16, 2025. This firm fixed-price delivery order, designated GXMRSA-NXG-10, carries no set-aside designation and represents a continuation of the federal government's ongoing relationship with Cepheid for diagnostic testing capabilities. The...
- The U.S. Defense Department's Medical Supply Chain awarded a $11,968.00 firm fixed-price delivery order to Cepheid Inc. on August 4, 2025, for molecular diagnostic solutions with an ultimate completion date of August 18, 2025. This delivery order, which carries no set-aside designation, is likely issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts with the Veterans Integrated Service Networks, such as the $32.8M IDV with VA VISN 6 or the $2.5M IDV with VA VISN...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F5X6LDelivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $1,930.72 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on May 2, 2025, with an ultimate completion date of May 9, 2025. The contract, designated as XPRSMVP-10, carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing, with its GeneXpert diagnostic platform serving as a cornerstone product for federal healthcare systems. This delivery order aligns with Cepheid's ongoing role as a primary supplier of molecular diagnostic solutions across multiple federal agencies, including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency. The company's federal portfolio emphasizes testing capabilities for infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other pathogens critical to military and veteran healthcare operations. With existing IDV contracts valued at over $35 million across VA networks, Cepheid maintains a significant competitive position in the federal molecular diagnostics procurement landscape, supporting both diagnostic equipment and reagent supply chains through firm fixed-price mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 5/2/25 |